BioNews – Gene therapy halts fatal child brain diseaseBioNewsA new gene therapy has halted the progression of a fatal degenerative brain disease in a small study of affected boys. Until now, the only effective treatment … Continue reading
BioNews – Gene therapy halts fatal child brain diseaseBioNewsA new gene therapy has halted the progression of a fatal degenerative brain disease in a small study of affected boys. Until now, the only effective treatment … Continue reading
|
Aduro Biotech Announces Upcoming Data Presentations at the Society for Immunotherapy of Cancer’s 32nd Annual …
GlobeNewswire (press release) BERKELEY, Calif., Oct. 09, 2017 (GLOBE NEWSWIRE) — Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, today announced data presentations relating to its technology platforms to be given … |
Business Insider |
Meet the 30 biotech leaders under 40 who are searching for breakthrough treatments and shaping the future of medicine
Business Insider Tim Lu, associate professor of biological engineering, electrical engineering, and computer science at MIT, runs the Synthetic Biology Group at MIT, where he’s worked to develop synthetic biology that’s programmed to be more precise therapies. |
|
AZ files immunotherapy Imfinzi in Europe – PharmaTimes
PharmaTimes AstraZeneca has submitted the first marketing application in Europe for its immunotherapy Imfinzi, seeking approval for the drug’s use to treat a subset of patients … |
STAT |
Spark’s novel gene therapy for blindness is racing to a historic date with the FDA
STAT On Thursday, a committee of experts invited by the FDA will meet outside Washington D.C. to review an experimental gene therapy from Spark Therapeutics (ONCE 1). Barring unexpected surprises, the experts will advise the FDA to approve the one-time shot … |